Shine-On BioMedical Co.,Ltd.

TWO:6926 Taiwan Biotechnology

Market Cap

$99.79 Million

NT$3.30 Billion TWD

Market Cap Rank

#23128 Global

#1360 in Taiwan

Share Price

NT$66.30

Change (1 day)

-0.75%

52-Week Range

NT$65.80 - NT$71.20

All Time High

NT$71.20

Shine-On BioMedical Co.,Ltd. - Asset Resilience Ratio

Latest as of June 2025: 95.31%

Shine-On BioMedical Co.,Ltd. (6926) has an Asset Resilience Ratio of 95.31% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$936.00 Million

Cash + Short-term Investments

Total Assets

NT$982.08 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Shine-On BioMedical Co.,Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Shine-On BioMedical Co.,Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$936.00 Million	95.31%
Total Liquid Assets	NT$936.00 Million	95.31%

Asset Resilience Insights

Very High Liquidity: Shine-On BioMedical Co.,Ltd. maintains exceptional liquid asset reserves at 95.31% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.